Related Experiment Video
Updated: Mar 17, 2026

11:00
Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
Published on: June 12, 2018
14.7K
Ubiquitin-specific peptidase 2 as a potential link between microRNA-125b and psoriasis
T Wei1, L Folkersen2, E Biskup1
1Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark.
The British Journal of Dermatology
|August 2, 2016
Summary
This study identifies ubiquitin-specific peptidase 2 as a key player in psoriasis, regulated by microRNA-125b. The findings reveal how this interaction modulates inflammation, offering new insights into psoriasis pathogenesis and personalized medicine.
Area of Science:
- Dermatology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are extensively involved in psoriasis pathophysiology.
- Detailed functional mechanisms are crucial for therapeutic manipulation of miRNA levels.
- miR-125b is strongly associated with psoriasis, warranting further investigation.
Purpose of the Study:
- To elucidate the specific pathway and mechanism linking miR-125b to psoriasis.
- To identify the functional role of miR-125b in the context of psoriasis.
Main Methods:
- A three-step bioinformatical pipeline identified candidate genes based on miR-125b binding, psoriatic lesion expression, and GWAS data.
- Candidate gene validation involved luciferase assays, in vitro overexpression, siRNA knock-down, and downstream gene analysis.
Main Results:
- Ubiquitin-specific peptidase 2 (USP2) was identified as a likely candidate gene.
- A direct link between miR-125b and USP2 was established.
- Modulation of nuclear factor kappa B (NF-κB)-mediated inflammation was identified as the mechanism of action.
Conclusions:
- Understanding the multifactorial causes of psoriasis is essential for improved therapeutic control.
- This research elucidates a novel miRNA-gene interaction in psoriasis pathogenesis.
- Findings contribute to the advancement of personalized medicine for psoriasis management.
More Related Videos
Related Concept Videos
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs
24.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Receptor Downregulation in MVBs
2.9K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.9K
Regulation of the Unfolded Protein Response
3.2K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
The Proteasome
1.9K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.9K
The Proteasome
10.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K

